ClinVar Genomic variation as it relates to human health
NM_004055.5(CAPN5):c.865C>T (p.Arg289Trp)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_004055.5(CAPN5):c.865C>T (p.Arg289Trp)
Variation ID: 279987 Accession: VCV000279987.16
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 11q13.5 11: 77115560 (GRCh38) [ NCBI UCSC ] 11: 76826606 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Dec 6, 2016 Oct 8, 2024 Oct 7, 2022 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_004055.5:c.865C>T MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_004046.2:p.Arg289Trp missense NC_000011.10:g.77115560C>T NC_000011.9:g.76826606C>T NG_033002.1:g.53615C>T - Protein change
- R289W
- Other names
- -
- Canonical SPDI
- NC_000011.10:77115559:C:T
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
-
protein gain of function; Variation Ontology [ VariO:0040]
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
CAPN5 | - | - |
GRCh38 GRCh37 |
601 | 629 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (2) |
criteria provided, multiple submitters, no conflicts
|
Oct 7, 2022 | RCV000389248.10 | |
Pathogenic (2) |
criteria provided, single submitter
|
May 25, 2020 | RCV000626481.6 | |
Pathogenic (1) |
criteria provided, single submitter
|
Mar 12, 2020 | RCV001267244.4 | |
CAPN5-related disorder
|
Pathogenic (1) |
no assertion criteria provided
|
Apr 24, 2024 | RCV004757186.1 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Mar 05, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000329671.8
First in ClinVar: Dec 06, 2016 Last updated: Mar 04, 2023 |
Comment:
Published functional studies demonstrate altered enzymatic activity (Velez et al., 2018) and the mutant mouse model exhibits a phenotype similar to that seen in humans … (more)
Published functional studies demonstrate altered enzymatic activity (Velez et al., 2018) and the mutant mouse model exhibits a phenotype similar to that seen in humans (Wang et al., 2018); Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 32707200, 30986125, 31403230, 29472286, 29610848, 29245980) (less)
|
|
Pathogenic
(May 25, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
Proliferative vitreoretinopathy
(Autosomal dominant inheritance)
Affected status: yes
Allele origin:
de novo
|
Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München
Accession: SCV001430062.1
First in ClinVar: Aug 21, 2020 Last updated: Aug 21, 2020 |
Clinical Features:
Pigmentary retinopathy (present) , Hepatomegaly (present) , Bilateral sensorineural hearing impairment (present) , Elevated circulating creatinine concentration (present) , Global developmental delay (present)
Sex: male
Tissue: blood
|
|
Pathogenic
(Oct 07, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV001588515.4
First in ClinVar: May 10, 2021 Last updated: Feb 20, 2024 |
Comment:
For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects CAPN5 function (PMID: 29472286). Advanced modeling … (more)
For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects CAPN5 function (PMID: 29472286). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on CAPN5 protein function. ClinVar contains an entry for this variant (Variation ID: 279987). This missense change has been observed in individual(s) with autosomal dominant neovascular inflammatory vitreoretinopathy (PMID: 29472286, 30986125). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 289 of the CAPN5 protein (p.Arg289Trp). (less)
|
|
Pathogenic
(Mar 12, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
Inborn genetic diseases
Affected status: unknown
Allele origin:
germline
|
Ambry Genetics
Accession: SCV001445425.4
First in ClinVar: Nov 21, 2020 Last updated: May 01, 2024 |
Comment:
The alteration results in an amino acid change:_x000D_ _x000D_ The c.865C>T (p.R289W) alteration is located in exon 6 (coding exon 5) of the CAPN5 gene. … (more)
The alteration results in an amino acid change:_x000D_ _x000D_ The c.865C>T (p.R289W) alteration is located in exon 6 (coding exon 5) of the CAPN5 gene. This alteration results from a C to T substitution at nucleotide position 865, causing the arginine (R) at amino acid position 289 to be replaced by a tryptophan (W). The alteration is not observed in healthy cohorts:_x000D_ _x000D_ Based on data from the Genome Aggregation Database (gnomAD), the CAPN5 c.865C>T alteration was not observed, with coverage at this position. The alteration has been observed in affected individuals: _x000D_ _x000D_ This alteration has been reported in a large Chinese family with 9 individuals in 4 generations affected with vitreoretinopathy, cataracts and retinitis pigmentosa starting in childhood, and it segregated with all affected individuals in that family (Wang, 2018). In addition, it has been reported de novo in two unrelated patients with vitreoretinopathy, hearing loss, and additional findings (O'Keefe, 2019; Velez, 2018). The altered amino acid is conserved throughout evolution:_x000D_ _x000D_ The p.R289 amino acid is conserved in available vertebrate species through reptiles. Functional analysis reveals a damaging effect of the amino acid alteration: _x000D_ _x000D_ A mouse model harboring this alteration was found to have an abnormally proliferative retinal pigment epithelium (RPE) layer (Wang, 2018) and in vitro studies have demostrated a gain-of-function effect with hyperactivation of the calpain protease even in the absence of calcium levels typically required for activation of wild type CAPN5 (Velez, 2018). The alteration is predicted tolerated by in silico modeling:_x000D_ _x000D_ The p.R289W alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, this alteration is classified as pathogenic. (less)
|
|
Pathogenic
(-)
|
no assertion criteria provided
Method: research
|
Proliferative vitreoretinopathy
(Sporadic)
Affected status: yes
Allele origin:
de novo
|
Omics Laboratory, Stanford University
Accession: SCV000611753.1
First in ClinVar: May 09, 2018 Last updated: May 09, 2018 |
Indication for testing: VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY, VRNI
Sex: male
Ethnicity/Population group: Caucasian
Testing laboratory: GeneDx
Testing laboratory interpretation: Pathogenic
|
|
Pathogenic
(Apr 24, 2024)
|
no assertion criteria provided
Method: clinical testing
|
CAPN5-related condition
Affected status: unknown
Allele origin:
germline
|
PreventionGenetics, part of Exact Sciences
Accession: SCV005362644.1
First in ClinVar: Oct 08, 2024 Last updated: Oct 08, 2024 |
Comment:
The CAPN5 c.865C>T variant is predicted to result in the amino acid substitution p.Arg289Trp. This variant has been reported as de novo in four pediatric … (more)
The CAPN5 c.865C>T variant is predicted to result in the amino acid substitution p.Arg289Trp. This variant has been reported as de novo in four pediatric patients with vitreoretinopathy phenotypes (Velez et al. 2018. PubMed ID: 29472286; O'Keefe et al. 2019. PubMed ID: 30986125; Xia et al. 2022. PubMed ID: 36369866). This variant was also reported in a patient from a posterior segment uveitis cohort (Li et al. 2020. PubMed ID: 32707200). A functional analysis showed that this variant had a gain of function effect, leading to increased the proteolytic activity of CAPN5 (Velez et al. 2018. PubMed ID: 29472286). This variant has not been reported in a large population database, indicating this variant is rare and has been interpreted as pathogenic by multiple submitters in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/279987/). This variant is interpreted as pathogenic. (less)
|
Germline Functional Evidence
Functional
Help
The functional consequence of the variant, based on experimental evidence and provided by the submitter. consequence |
Method
Help
A brief description of the method used to determine the functional consequence of the variant. A citation for the method is included, when provided by the submitter. |
Result
Help
A brief description of the result of this method for this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting functional evidence for the germline classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
---|---|---|---|---|
protein gain of function
|
|
|
Omics Laboratory, Stanford University
Accession: SCV000611753.1
|
|
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Early Onset Neovascular Inflammatory Vitreoretinopathy Due to a De Novo CAPN5 Mutation: Report of a Case. | O'Keefe G | Ocular immunology and inflammation | 2019 | PMID: 30986125 |
Photoreceptor Cell-Derived CAPN5 Regulates Retinal Pigment Epithelium Cell Proliferation Through Direct Regulation of SLIT2 Cleavage. | Wang Y | Investigative ophthalmology & visual science | 2018 | PMID: 29610848 |
A novel de novo CAPN5 mutation in a patient with inflammatory vitreoretinopathy, hearing loss, and developmental delay. | Velez G | Cold Spring Harbor molecular case studies | 2018 | PMID: 29472286 |
Text-mined citations for rs886041303 ...
HelpRecord last updated Oct 13, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.